Related Experiment Videos
Avian retroviral recombinant expressing foreign envelope delays tumour formation of ASV-A-induced sarcoma
1Viral Oncology Laboratory, VA Medical Center, Salt Lake City, UT.
Vaccine
|January 1, 1992
Abstract:
An avian recombinant retrovirus expressing subgroup A envelope glycoprotein antigenicity, RAV-0-A1, significantly delayed sarcoma induction in chickens after challenge with ASV-A. When tumours were formed, significantly smaller tumours resulted. The mechanism of protection does not appear to be interference mediated, since virus was not detected in the chickens. Protection was correlated with both neutralizing and complement-dependent cytotoxic antibodies (CDCA).